IQVIA Biotech’s Post

Whether it's cystic fibrosis or ulcerative colitis, we understand the unique nuances of internal medicine trials. Recognizing the need for customized strategies across subspecialties, our team of therapeutically aligned experts take a tailored approach to navigating the complexities of your clinical trial – developing and implementing optimal clinical strategies, and maximizing patient impact. Learn more. https://bit.ly/4i1MGay #InternalMedicine #clinicaltrials

Whether it's cystic fibrosis or ulcerative colitis, we understand the unique nuances of internal medicine trials. Recognizing the need for customized strategies across subspecialties, our team of therapeutically aligned experts take a tailored approach to navigating the complexities of your clinical trial – developing and implementing optimal clinical strategies, and maximizing patient impact. Learn more. https://bit.ly/40j8oAG #InternalMedicine #clinicaltrials

Whether it's cystic fibrosis or ulcerative colitis, we understand the unique nuances of internal medicine trials. Recognizing the need for customized strategies across subspecialties, our team of therapeutically aligned experts take a tailored approach to navigating the complexities of your clinical trial – developing and implementing optimal clinical strategies, and maximizing patient impact. Learn more. https://bit.ly/4deee94 #InternalMedicine #clinicaltrials

Our informational symposium at #ASPN2024 starts at noon tomorrow and will emphasize the evidence behind Prospera™: ➡️ Learn about a robust clinical program that dates back to 2017 and includes multiple studies supporting therapy development, therapy validation, and a real-world study that validates the need for patient support beyond the implant. ➡️ Hear how proactive care is positively impacting patients, as demonstrated by real-world results from clinical practice. Don’t miss this opportunity to register: https://ow.ly/yf9M50Sv2Uu #BIOTRONIKNeuro #SpinalCordStimulation

This study aims to evaluate the relationship between cluster headache onset and response to therapy. This is an important question that can influence treatment decisions in clinical practice, as well as clinical trial design. https://lnkd.in/dNUxNrZB #headache #clusterheadache

We are excited to share news about our GRACE clinical trial and look forward to providing more insights about this pivotal Phase 3 study of patients with #hypercortisolism soon. Read more in today’s press release: https://bit.ly/45gVLqh #CortisolModulation #ClinicalTrial

Just published 📖 𝗖𝗮𝗻𝗮𝗱𝗶𝗮𝗻 𝗖𝗼𝗻𝘀𝗲𝗻𝘀𝘂𝘀 𝗦𝘁𝗮𝘁𝗲𝗺𝗲𝗻𝘁 𝗼𝗻 𝘁𝗵𝗲 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗩𝗲𝗻𝗼𝘂𝘀 𝗟𝗲𝗴 𝗨𝗹𝗰𝗲𝗿𝘀 (𝗩𝗟𝗨𝘀) Recently published in Wound Care Canada and developed by a diverse panel of experts, the Consensus Statement is an up-to-date practical guide for health-care providers managing patients with VLUs. The guide incorporates the latest clinical research, including the use of muscle pump activators (MPAs,) such as The geko® device, which significantly improve healing rates and patient outcomes. Key highlights include diagnosis and assessment of VLU’s, VLU treatment strategies, effective wound care recommendations and emphasis on patient education and prevention of recurrence. Click here for the Consensus Statement: https://lnkd.in/eG5hducz And here to learn more about the geko device: https://lnkd.in/e-6tnSp2

How much do you know about clinical trials? May is #CancerResearchMonth and Clinical Trials Save Lives! At LACN, we have a robust research program and have many trials available for eligible patients. Ask your doctor about it today! You can also read more about our trials on our website here: https://loom.ly/8Fcx050 #clinicalresearch #cancerresearch #clinicaltrials

These Clinical Lab Products case studies detail how SeptiCyte® RAPID differentiated between #sepsis and SIRS in two #EmergencyDepartment patients. SeptiCyte® RAPID improved turnaround times and diagnostic accuracy, buying clinicians critical time to administer life-saving treatments. Read the full article here: https://lnkd.in/euVQQhfF

🥸 News you can use. In this article, the FDA cleared SeptiCyte RAPID - host-response, gene-expression test, shows utility of sepsis diagnosis in two case studies illustrate how this novel life-saving sepsis test improves turnaround times and diagnostic accuracy, buying clinicians critical time to administer time sensitive treatments and reduce mortality 💜! DM me to schedule a meeting. #sepsis #infectionprevention #ICU #ED #EM #Moleculardiagnostics #patientsafety